298 related articles for article (PubMed ID: 29566713)
41. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
42. PIMREG, a Marker of Proliferation, Facilitates Aggressive Development of Cholangiocarcinoma Cells Partly Through Regulating Cell Cycle-Related Markers.
Jiang ZM; Li HB; Chen SG
Technol Cancer Res Treat; 2020; 19():1533033820979681. PubMed ID: 33356974
[TBL] [Abstract][Full Text] [Related]
43. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
Ko PH; Lenka G; Chen YA; Chuang EY; Tsai MH; Sher YP; Lai LC
Int J Oncol; 2020 Jan; 56(1):165-177. PubMed ID: 31789397
[TBL] [Abstract][Full Text] [Related]
44. Research progress and therapeutic prospect of PHF5A acting as a new target for malignant tumors.
Li M; Cheng Q; Wang X; Yang Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):647-655. PubMed ID: 36581580
[TBL] [Abstract][Full Text] [Related]
45. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
[TBL] [Abstract][Full Text] [Related]
46. A novel PHD-finger protein 14/KIF4A complex overexpressed in lung cancer is involved in cell mitosis regulation and tumorigenesis.
Zhang L; Huang Q; Lou J; Zou L; Wang Y; Zhang P; Yang G; Zhang J; Yu L; Yan D; Zhang C; Qiao J; Wang S; Wang S; Xu Y; Ji H; Chen Z; Zhang Z
Oncotarget; 2017 Mar; 8(12):19684-19698. PubMed ID: 28160558
[TBL] [Abstract][Full Text] [Related]
47. MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway.
Zou H; Chen Q; Zhang A; Wang S; Wu H; Yuan Y; Wang S; Yu J; Luo M; Wen X; Cui W; Fu W; Yu R; Chen L; Zhang M; Lan H; Zhang X; Xie Q; Jin G; Xu C
Cell Death Dis; 2019 Feb; 10(3):148. PubMed ID: 30770798
[TBL] [Abstract][Full Text] [Related]
48. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
50. CASTOR1 suppresses the progression of lung adenocarcinoma and predicts poor prognosis.
Zhou X; Cheng Z; Chen H; Shi S; Wang X; Orang M; Zhao J
J Cell Biochem; 2018 Dec; 119(12):10186-10194. PubMed ID: 30132978
[TBL] [Abstract][Full Text] [Related]
51. MARCH9 Suppresses Lung Adenocarcinoma Progression by Downregulating ICAM-1.
Shen QM; Wang HY; Xu S
Cell Physiol Biochem; 2018; 50(1):92-107. PubMed ID: 30278450
[TBL] [Abstract][Full Text] [Related]
52. Knockdown of MMP12 inhibits the growth and invasion of lung adenocarcinoma cells.
Lv FZ; Wang JL; Wu Y; Chen HF; Shen XY
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):77-84. PubMed ID: 25816409
[TBL] [Abstract][Full Text] [Related]
53. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
[TBL] [Abstract][Full Text] [Related]
54. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.
Hubert CG; Bradley RK; Ding Y; Toledo CM; Herman J; Skutt-Kakaria K; Girard EJ; Davison J; Berndt J; Corrin P; Hardcastle J; Basom R; Delrow JJ; Webb T; Pollard SM; Lee J; Olson JM; Paddison PJ
Genes Dev; 2013 May; 27(9):1032-45. PubMed ID: 23651857
[TBL] [Abstract][Full Text] [Related]
56. CHPF promotes lung adenocarcinoma proliferation and anti-apoptosis via the MAPK pathway.
Hou XM; Zhang T; Da Z; Wu XA
Pathol Res Pract; 2019 May; 215(5):988-994. PubMed ID: 30826152
[TBL] [Abstract][Full Text] [Related]
57. UHRF1 predicts poor prognosis by triggering cell cycle in lung adenocarcinoma.
Tu Z; Deng X; Hou S; Feng A; Zhang Q
J Cell Mol Med; 2020 Jul; 24(14):8069-8077. PubMed ID: 32495469
[TBL] [Abstract][Full Text] [Related]
58. SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.
Han F; Zhang MQ; Liu WB; Sun L; Hao XL; Yin L; Jiang X; Cao J; Liu JY
Respir Res; 2018 Dec; 19(1):241. PubMed ID: 30514297
[TBL] [Abstract][Full Text] [Related]
59. Identification of prognostic genes through expression differentiation during metastatic process in lung adenocarcinoma.
An N; Yang X
Sci Rep; 2017 Sep; 7(1):11119. PubMed ID: 28894185
[TBL] [Abstract][Full Text] [Related]
60. Heat shock factor 1 inhibits the mitochondrial apoptosis pathway by regulating second mitochondria-derived activator of caspase to promote pancreatic tumorigenesis.
Liang W; Liao Y; Zhang J; Huang Q; Luo W; Yu J; Gong J; Zhou Y; Li X; Tang B; He S; Yang J
J Exp Clin Cancer Res; 2017 May; 36(1):64. PubMed ID: 28482903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
